Literature DB >> 18048819

Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.

Carol Tishelman1, Lena-Marie Petersson, Lesley F Degner, Mirjam A G Sprangers.   

Abstract

PURPOSE: To examine symptom prevalence, intensity, and association with distress in patients with inoperable lung cancer (LC), using time to death as point of reference. PATIENTS AND METHODS: A consecutive sample of 400 patients completed the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 plus a 13-item LC-specific scale and the Thurstone Scale of Symptom Distress-Lung Cancer at six time points during the first year after diagnosis. Patients were divided into subgroups, using data from the time point closest to death (< 1; 1 to 2; > 2 to 3; > 3 to 6; > 6 to 12; and > 12 months before death) for analysis.
RESULTS: More than 50% of patients in all subgroups reported problems related to physical, role, and emotional functioning; fatigue; dyspnea; and cough. In general, functional levels were lower and symptoms higher in subgroups closer to death. Notably, clinically relevant differences were also found in role and social functioning and appetite loss between the two groups furthest from death. A consistent pattern was found among the six subgroups, with breathing, pain, and fatigue rated as the symptoms most associated with distress.
CONCLUSION: High prevalence of symptoms was found in all subgroups, with higher intensity in subgroups closer to death, indicating a need for prophylactic and proactive symptom management. Less concordance was found among symptom prevalence, intensity, and association with distress in subgroups further from death. Future studies should investigate longitudinal associations between symptoms with low intensity and high distress, and examine their clinical implications.

Entities:  

Mesh:

Year:  2007        PMID: 18048819     DOI: 10.1200/JCO.2006.08.7874

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  42 in total

1.  Trans-bronchoscopy with implantation of 125I radioactive seeds in patients with pulmonary atelectasis induced by lung cancer.

Authors:  Mingjian Lu; Deli Pu; Weidong Zhang; Jiangrong Liao; Tao Zhang; Guang Yang; Zhenyin Liu; Sristi Singh; Fei Gao; Fujun Zhang
Journal:  Oncol Lett       Date:  2015-05-13       Impact factor: 2.967

Review 2.  Hypnosis for Symptom Control in Cancer Patients at the End-of-Life: A Systematic Review.

Authors:  Guy H Montgomery; Madalina Sucala; Tessa Baum; Julie B Schnur
Journal:  Int J Clin Exp Hypn       Date:  2017 Jul-Sep

Review 3.  Dyspnea in lung cancer patients: a systematic review.

Authors:  Ganesan Kathiresan; Reynold F Clement; Meera T Sankaranarayanan
Journal:  Lung Cancer (Auckl)       Date:  2010-11-22

4.  Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders.

Authors:  Daniel C McFarland; Kelly M Shaffer; Heather Polizzi; John Mascarenhas; Marina Kremyanskaya; Jimmie Holland; Ronald Hoffman
Journal:  J Natl Compr Canc Netw       Date:  2017-12       Impact factor: 11.908

5.  Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial.

Authors:  David Hui; Angela Xu; Susan Frisbee-Hume; Gary Chisholm; Margarita Morgado; Suresh Reddy; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2013-07-03       Impact factor: 3.612

6.  The unmet supportive care needs-what advanced lung cancer patients' caregivers need and related factors.

Authors:  Shu-Ching Chen; Shiuan-Chen Chiou; Chong-Jen Yu; Yun-Hsiang Lee; Wei-Yu Liao; Pei-Yin Hsieh; Sin-Yuan Jhang; Yeur-Hur Lai
Journal:  Support Care Cancer       Date:  2016-02-13       Impact factor: 3.603

7.  Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study.

Authors:  David Hui; Henrique Parsons; Linh Nguyen; Shana L Palla; Sriram Yennurajalingam; Razelle Kurzrock; Eduardo Bruera
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

8.  Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients.

Authors:  David B Bekelman; John S Rumsfeld; Edward P Havranek; Traci E Yamashita; Evelyn Hutt; Sheldon H Gottlieb; Sydney M Dy; Jean S Kutner
Journal:  J Gen Intern Med       Date:  2009-03-14       Impact factor: 5.128

9.  Spontaneous reports of most distressing concerns in patients with inoperable lung cancer: at present, in retrospect and in comparison with EORTC-QLQ-C30+LC13.

Authors:  Eva Broberger; Carol Tishelman; Louise von Essen; Eva Doukkali; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2007-10-06       Impact factor: 4.147

10.  Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.

Authors:  Xin Shelley Wang; Qiuling Shi; Charles Lu; Ethan M Basch; Valen E Johnson; Tito R Mendoza; Gary M Mobley; Charles S Cleeland
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.